Finally, another study showed that combination of both CTLA-4 and PD1 blocking antibodies with GM-CSF-expressing tumor cell vaccine also efficiently promoted tumor rejection in mouse models of colon carcinoma and ovarian cancer [179, 180]. This evidence concerns the gene PDCD1 and colon carcinoma.